Details for New Drug Application (NDA): 214657
✉ Email this page to a colleague
The generic ingredient in PEMETREXED DISODIUM is pemetrexed disodium. There are twenty-nine drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the pemetrexed disodium profile page.
Summary for 214657
Tradename: | PEMETREXED DISODIUM |
Applicant: | Sandoz |
Ingredient: | pemetrexed disodium |
Patents: | 0 |
Pharmacology for NDA: 214657
Mechanism of Action | Folic Acid Metabolism Inhibitors |
Medical Subject Heading (MeSH) Categories for 214657
Suppliers and Packaging for NDA: 214657
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PEMETREXED DISODIUM | pemetrexed disodium | SOLUTION;INTRAVENOUS | 214657 | NDA | Sandoz Inc. | 0781-3518 | 0781-3518-76 | 1 VIAL in 1 CARTON (0781-3518-76) / 4 mL in 1 VIAL |
PEMETREXED DISODIUM | pemetrexed disodium | SOLUTION;INTRAVENOUS | 214657 | NDA | Sandoz Inc. | 0781-3519 | 0781-3519-90 | 1 VIAL in 1 CARTON (0781-3519-90) / 20 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | EQ 100MG BASE/4ML (EQ 25MG BASE/ML) | ||||
Approval Date: | May 26, 2022 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | EQ 500MG BASE/20ML (EQ 25MG BASE/ML) | ||||
Approval Date: | May 26, 2022 | TE: | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | EQ 1GM BASE/40ML (EQ 25MG BASE/ML) | ||||
Approval Date: | May 26, 2022 | TE: | RLD: | Yes |
Complete Access Available with Subscription